Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sangamo Therapeutics Inc (NASDAQ:SGMO)

9.90
Delayed Data
As of Aug 18
 -0.35 / -3.41%
Today’s Change
2.65
Today|||52-Week Range
12.05
+224.59%
Year-to-Date

Today’s Trading

Previous close10.25
Today’s open10.25
Day’s range9.80 - 10.45
Volume1,674,911
Average volume (3 months)1,478,710
Market cap$827.7M
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-75.86%
Earnings growth (this year)+15.40%
Earnings growth (next 5 years)+24.50%
Revenue growth (last year)-50.96%
P/E ratioNM
Price/Sales11.10
Price/Book5.15

Competitors

 Today’s
change
Today’s
% change
EPZMEpizyme Inc-0.05-0.35%
FPRXFive Prime Therapeut...-0.44-1.54%
MYOVMyovant Sciences Ltd+1.61+13.96%
CRSPCRISPR Therapeutics ...-0.08-0.43%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateOctober 25, 2017
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$19.4M
Annual profit (last year)-$71.7M
Net profit margin-369.58%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Alexander Macrae
Chief Financial Officer &
Senior Vice President
Kathy Yi
Corporate headquarters
Richmond, California

Forecasts